1. Home
  2. CEVA vs CERT Comparison

CEVA vs CERT Comparison

Compare CEVA & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CEVA Inc.

CEVA

CEVA Inc.

HOLD

Current Price

$35.02

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Certara Inc.

CERT

Certara Inc.

HOLD

Current Price

$7.72

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CEVA
CERT
Founded
1999
2008
Country
United States
United States
Employees
N/A
1576
Industry
Semiconductors
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
CEVA
CERT
Price
$35.02
$7.72
Analyst Decision
Strong Buy
Buy
Analyst Count
6
10
Target Price
$30.33
$11.67
AVG Volume (30 Days)
598.8K
3.7M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.50
EPS
N/A
N/A
Revenue
$87,507,000.00
$418,838,000.00
Revenue This Year
$12.37
$4.18
Revenue Next Year
$13.82
$5.39
P/E Ratio
N/A
N/A
Revenue Growth
20.45
8.75
52 Week Low
$17.02
$4.45
52 Week High
$51.60
$13.88

Technical Indicators

Market Signals
Indicator
CEVA
CERT
Relative Strength Index (RSI) 37.41 70.32
Support Level $18.67 $5.93
Resistance Level $49.89 $9.80
Average True Range (ATR) 2.65 0.35
MACD -0.87 0.03
Stochastic Oscillator 6.18 83.39

Price Performance

Historical Comparison
CEVA
CERT

About CEVA CEVA Inc.

CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived mainly from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems. The company operates in one reportable segment: the licensing of IP to semiconductor companies and electronic equipment manufacturers.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: